ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
NurExone Biologic Inc

NurExone Biologic Inc (J90)

0,412
-0,002
(-0,48%)
Geschlossen 08 Februar 10:00PM
Echtzeitdaten

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
0,412
Gebot
0,394
Fragen
0,462
Volumen
14.205
0,40 Tagesbereich 0,436
0,212 52-Wochen-Bereich 0,92
Handelsende
0,414
Handelsbeginn
0,436
Letzte Trade
1000
@
0.4
Letzter Handelszeitpunkt
Durchschnittliches Volumen (3 Mio.)
70.369
Finanzvolumen
-
VWAP
-

J90 Neueste Nachrichten

NurExone Forms Exo-Top Inc. in the U.S. for Exosome Manufacture and Commercialization

TORONTO and HAIFA, Israel, Feb. 05, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (“NurExone” or the “Company”) is pleased to announce the formation...

NurExone Secures C$1.2 Million through Warrant Exercises and Completion of Private Placement and Appoints New R&D Director

TORONTO and HAIFA, Israel, Jan. 21, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (“NurExone” or the “Company”), a developer of exosome-based...

NurExone Biologic Secures Master Cell Bank

TORONTO and HAIFA, Israel, Jan. 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) ("NurExone" or the "Company"), a developer of exosome-based...

NurExone Announces Promising Preclinical Results in Restoring Vision After Optic Nerve Damage

TORONTO and HAIFA, Israel, Dec. 06, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) ("NurExone" or the "Company"), a biopharmaceutical company...

NurExone Reports Third Quarter 2024 Financial Results and Provides Corporate Update

TORONTO and HAIFA, Israel, Nov. 27, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical...

NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets

TORONTO and HAIFA, Israel, Nov. 13, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) ("NurExone" or the "Company"), a biopharmaceutical company...

NurExone Biologic Closes Final Tranche of Non-Brokered Private Placement and Provides Corporate Update

TORONTO and HAIFA, Israel, Nov. 01, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a biopharmaceutical company...

NurExone’s Regenerative Medicine Therapies To Be Recognized at Fall Conferences in the USA

TORONTO and HAIFA, Israel, Oct. 23, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a biopharmaceutical company...

NurExone Biologic Announces Private Placement of up to $2M and Closes First Tranche for $1.61M

TORONTO and HAIFA, Israel, Sept. 26, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a biopharmaceutical company...

NurExone Biologic Extends Global Reach with Presentations at Industry-Leading Conferences

TORONTO and HAIFA, Israel, Sept. 12, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a biopharmaceutical company...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.0225.641025641030.390.4360.372256530.42632852DE
4-0.056-11.96581196580.4680.4840.37342500.41610031DE
12-0.044-9.649122807020.4560.57999990.37703690.48632514DE
260.037.853403141360.3820.57999990.324545770.45551727DE
520.1985.58558558560.2220.920.2121115440.52938068DE
1560.262174.6666666670.150.920.151037760.51650759DE
2600.262174.6666666670.150.920.151037760.51650759DE

J90 - Frequently Asked Questions (FAQ)

What is the current NurExone Biologic share price?
The current share price of NurExone Biologic is 0,412 €
What is the 1 year trading range for NurExone Biologic share price?
NurExone Biologic has traded in the range of 0,212 € to 0,92 € during the past year
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
CMWChina Communications Services Corp
39,89 €
(7.219,27%)
152
3YBPostal Savings Bank of China
39,55 €
(6.838,60%)
3,7k
YUE1Yue Yuen Industrial Holdings Ltd
39,875 €
(1.763,32%)
3,12k
CJHCanSino Biologics Inc
7,256 €
(96,11%)
281
0ZBConverge Technology Solutions Corp
3,656 €
(53,68%)
75,08k
1RR1Rokmaster Resources Corp
0,003 €
(-76,00%)
6k
9SHShake Shack Inc
39,60 €
(-64,28%)
202
E3O1Nexoptic Technology Corp
0,008 €
(-48,39%)
3,69k
POTAPortofino Resources Inc
0,0028 €
(-46,15%)
267,47k
D4GDataMetrex AI Ltd
0,0032 €
(-40,74%)
29,97k
M11First Graphene Limited
0,0458 €
(-16,73%)
3,19M
FMKEcograf Limited
0,0788 €
(18,32%)
2,41M
G7PAEnergy Transition Minerals Ltd
0,0492 €
(0,41%)
2,21M
3CPXiaomi Corporation
5,30 €
(5,37%)
2,19M
D7GNel ASA
0,198 €
(1,02%)
2,01M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock